Dr. Reddy's Laboratories Ltd (RDY) Social Stream



Dr. Reddy's Laboratories Ltd (RDY): $78.27

1.30 (-1.63%)

POWR Rating

Component Grades

Momentum

C

Stability

A

Sentiment

Quality

C

DR REDDYS LABORATORIES LTD (RDY) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering DR REDDYS LABORATORIES LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 2 $80 $75.7 $77.85 $69.38 12.21%
2022-01-06 2 $80 $75.5 $77.75 $69.38 12.06%
2022-01-28 1 $80 $68.5 $74.25 $69.38 7.02%
2022-03-30 1 $80 $66.4 $73.2 $69.38 5.51%
2022-04-28 1 $69 $66.4 $67.7 $69.38 -2.42%
2022-05-19 3 $69 $59 $64.466 $69.38 -7.08%
2022-06-21 3 $70 $59 $64.8 $69.38 -6.6%
2022-07-25 3 $68 $59 $65 $69.38 -6.31%
2022-08-13 3 $68 $57 $63.666 $69.38 -8.24%
2022-09-17 3 $69 $57 $64 $69.38 -7.75%
2022-10-13 3 $69 $57 $63.033 $69.38 -9.15%
2022-10-25 3 $66.001 $57 $62.033 $69.38 -10.59%
2022-10-30 3 $66.001 $57 $61.5 $69.38 -11.36%
2023-01-05 3 $67 $57 $62.266 $69.38 -10.25%
2023-01-27 3 $67 $57 $61.5 $69.38 -11.36%
2023-02-27 4 $67 $57 $61.533 $69.38 -11.31%
2023-03-16 4 $67 $60.6 $62.866 $69.38 -9.39%
2023-04-18 4 $67 $61 $65 $69.38 -6.31%
2023-05-10 4 $68 $64 $66.333 $69.38 -4.39%
2023-06-01 4 $70 $64 $67.333 $69.38 -2.95%
2023-06-20 4 $70 $67 $68.333 $69.38 -1.51%
2023-10-28 4 $77.5 $70 $73.5 $69.38 5.94%
2023-10-31 4 $77.5 $73 $75.166 $69.38 8.34%

The Trend in the Analyst Price Target


Over the past 40 weeks, RDY's average price target has gone up $13.67.

Over the past 42 weeks, RDY's average upside potential has been 14.22%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-27 4 67.0 57 61.500 53.34 15.3%
2023-02-27 4 67.0 57 61.533 53.74 14.5%
2023-06-20 4 70.0 67 68.333 60.41 13.12%
2023-10-27 4 77.5 70 73.500 65.05 12.99%
2023-10-31 4 77.5 73 75.166 65.13 15.41%

RDY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 0 0 1 1 4

The Trend in the Broker Recommendations


RDY's average broker recommendation rating worsened by 0.33 over the prior 17 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, DR REDDYS LABORATORIES LTD's number of analysts covering the stock is greater than 208.19% of them.
  • In terms of how DR REDDYS LABORATORIES LTD fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -24.56% of that group.
  • In terms of how DR REDDYS LABORATORIES LTD fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 361.69% of that group.
  • RDY has a higher average analyst price target than 2100.2% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, BGNE, GRFS, and CTLT are the three stocks most similar to DR REDDYS LABORATORIES LTD regarding the price target and analyst recommendation information presented here.

Is RDY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!